Press release
Anti-Inflammatory Therapeutics Market Report 2024: Strategies And Recent Developments| Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc
The Business Research Company offers in-depth market insights through Anti-Inflammatory Therapeutics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.Market Size And Growth Forecast:
The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $109.88 billion in 2023 to $114.71 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.
The anti-inflammatory therapeutics market size is expected to see steady growth in the next few years. It will grow to $135.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
Market Segmentation:
The main types of drug classes for anti-inflammatory therapeutics are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and anti-inflammatory biologics. Nonsteroidal anti-inflammatory drugs refer to non-opioid analgesic drugs that are typically used by people to relieve mild bodily pain symptoms. The various indications include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel diseases, and others, and are distributed through various distribution channels such as retail pharmacies, hospital pharmacies, and online distribution.
Anti Inflammatory Therapeutics Global Market Report 2023 provides data on the global anti inflammatory therapeutics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors' revenues, profiles and market shares. The anti inflammatory therapeutics market report identifies opportunities and strategies based on market trends and leading competitors' approaches.
Major Driver - Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflammatory Therapeutics Market
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the anti-inflammatory therapeutics market going forward. Inflammatory bowel disease (IBD) is a chronic illness resulting in inflammation of the gastrointestinal tract. Anti-inflammatory therapeutics play a crucial role in treating Crohn's disease by reducing inflammation, managing the symptoms of the disease, and reducing the risk of surgery. For instance, in July 2023, according to Oxford University Press (OUP), the university press of the University of Oxford, incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and the prevalence is 721 per 100,000 people. Therefore, the increasing prevalence of inflammatory bowel disease is driving the growth of the anti-inflammatory therapeutics market.
Competitive Landscape:
Major players in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
Top Trend - Innovative Drugs Strengthen Market Position Of Key Players In The Anti-Inflammatory Therapeutics Sector
Major companies operating in the anti-inflammatory therapeutics market are introducing innovative drugs to strengthen their position in the market. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, launched Kevzara (sarilumab). The first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, who don't respond adequately to corticosteroids or cannot endure corticosteroid tapering.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Anti-Inflammatory Therapeutics Market Characteristics
3. Anti-Inflammatory Therapeutics Market Trends And Strategies
4. Anti-Inflammatory Therapeutics Market - Macro Economic Scenario
5. Anti-Inflammatory Therapeutics Market Size And Growth
…..
27. Anti-Inflammatory Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Therapeutics Market Report 2024: Strategies And Recent Developments| Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc here
News-ID: 3404411 • Views: …
More Releases from The Business research company

Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…

Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…

High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…

Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…